135 related articles for article (PubMed ID: 22907641)
1. Recent advances in cancer stem cell research for cholangiocarcinoma.
Kokuryo T; Yokoyama Y; Nagino M
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):606-13. PubMed ID: 22907641
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
[TBL] [Abstract][Full Text] [Related]
3. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
[TBL] [Abstract][Full Text] [Related]
4. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.
Raggi C; Invernizzi P; Andersen JB
J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250
[TBL] [Abstract][Full Text] [Related]
5. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
[TBL] [Abstract][Full Text] [Related]
6. [A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy].
Yamada K; Sakamoto K; Tamesa T; Matsui H; Shindo Y; Tokumitsu Y; Hashimoto N; Iida M; Maeda Y; Tokuhisa Y; Suzuki N; Yoshimura K; Ueno T; Takahashi M; Shibuya K; Kondo T; Oka M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1756-8. PubMed ID: 24393912
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pathology of cholangiocarcinoma (intrahepatic bile duct cancer)].
Yamamoto M
Nihon Geka Hokan; 1995 Nov; 64(6):129-30. PubMed ID: 8913088
[No Abstract] [Full Text] [Related]
9. Distal cholangiocarcinoma.
Lad N; Kooby DA
Surg Oncol Clin N Am; 2014 Apr; 23(2):265-87. PubMed ID: 24560110
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD24 in cholangiocarcinoma cells is associated with disease progression and reduced patient survival.
Keeratichamroen S; Leelawat K; Thongtawee T; Narong S; Aegem U; Tujinda S; Praditphol N; Tohtong R
Int J Oncol; 2011 Oct; 39(4):873-81. PubMed ID: 21687942
[TBL] [Abstract][Full Text] [Related]
11. [A case of distal cholangiocarcinoma with high sensitivity to neoadjuvant chemoradiation therapy].
Haji Y; Mizuma M; Hayashi H; Nakagawa K; Okada T; Otsuka H; Ottomo S; Sakata N; Fukase K; Yoshida H; Onogawa T; Motoi F; Naito T; Rikiyama T; Katayose Y; Egawa S; Unno M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2426-8. PubMed ID: 22202402
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells.
Sangsuwannukul T; Supimon K; Sujjitjoon J; Phanthaphol N; Chieochansin T; Poungvarin N; Wongkham S; Junking M; Yenchitsomanus PT
Int Immunopharmacol; 2020 Dec; 89(Pt B):107069. PubMed ID: 33242709
[TBL] [Abstract][Full Text] [Related]
13. Comment on: isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
Gradilone A; Gazzaniga P; Raimondi C; Aglianò AM; Frati L
Int J Cancer; 2011 Apr; 128(8):1997-8. PubMed ID: 20568108
[No Abstract] [Full Text] [Related]
14. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer stem cells in cholangiocarcinoma (Review).
Mcgrath NA; Fu J; Gu SZ; Xie C
Int J Oncol; 2020 Aug; 57(2):397-408. PubMed ID: 32468022
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of neoadjuvant chemoradiation therapy for clinical Stage II cholangiocarcinoma as a preoperative diagnosis].
Nakagawa K; Katayose Y; Unno M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1945-7. PubMed ID: 23267938
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of peripheral intrahepatic cholangiocarcinoma with distant metastasis.
Izumi R; Shimizu K; Kiriyama M; Yagi M; Matsui O; Nonomura A; Miyazaki I
Am J Gastroenterol; 1995 Mar; 90(3):505-7. PubMed ID: 7872300
[No Abstract] [Full Text] [Related]
18. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
19. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma.
Vicent S; Lieshout R; Saborowski A; Verstegen MMA; Raggi C; Recalcati S; Invernizzi P; van der Laan LJW; Alvaro D; Calvisi DF; Cardinale V
Liver Int; 2019 May; 39 Suppl 1():79-97. PubMed ID: 30851232
[TBL] [Abstract][Full Text] [Related]
20. EUS-FNA in unresectable cholangiocarcinoma: a novel indication.
Pollack MJ; Gholam PM; Chak A
Gastrointest Endosc; 2008 Mar; 67(3):444-5. PubMed ID: 18294505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
